B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.

Abstract

In patients undergoing TAVI, plasma BNP is the strongest independent predictor of all-cause mortality and cardiovascular mortality. Plasma BNP levels at 30 days after TAVI may provide prognostic information that should, potentially, lead to a more intensive therapy of these patients.